This week, after years of anticipation (and a bit of public backlash), California’s iconic burger chain opened its first locations in Tennessee. The Volunteer State’s two new In-N-Outs, both in ...
In-N-Out plans to open its first Tennessee locations by the end of 2025. The company is opening a corporate hub in Franklin as part of its eastward expansion. Tennesseans will soon be enjoying ...
In-N-Out Burger to open at least some restaurants by the end of 2025. In-N-Out Burger plans to start serving customers in Middle Tennessee by the end of 2025, though the company wasn't specific about ...
LONGMONT, Colo. — In-N-Out Burger is celebrating the grand opening of a new Colorado restaurant on Thursday. The California-based fast food chain will open a new restaurant location in Longmont at ...
Austin H. can’t wait to buy a house and start a family. But right now, the 34-year-old is barely getting by. Austin is living paycheck to paycheck and saving almost no money, one of the millions of ...
Inside the financial engineering of the AI build-out: Nvidia, Google and the rest of Big Tech are turning to Wall Street, vendor financing and private credit In a rural Louisiana parish that is home ...
Recursion Pharmaceuticals currently has the industry's largest AI supercomputer. It also has partnerships with major drugmakers, but these have yet to yield major wins. Recursion'a lack of clinical ...
Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...
In-N-Out is bringing its classic burgers and “Animal Style Fries” to the Volunteer state. The California-based burger chain has five new locations “opening soon” in three states, including Tennessee, ...
New survey data finds that nearly 1 in 5 high schoolers say they or someone they know has had a romantic relationship with artificial intelligence. And 42% of students surveyed say they or someone ...
Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...